One of the principal tools of personalized medicine is the use of companion diagnostics. In this first article in a two-part series on the opportunities and challenges that confront the rise of companion diagnostics, we use case studies to review the different roles that these products and services could play in the continued growth of the pharmaceutical industry. The article can be found here:
Learning from the leaders: Value creating strategies in the chemical sector
Chemical company performance drivers In recent years, the gap between top- and bottom-tier performers in the chemical sector has remained wide, both in terms...